Trial Profile
An Open Label Study to Evaluate the Pharmacokinetics of ASP1707 After a Single Oral Dose of 14C-labeled ASP1707 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Opigolix (Primary)
- Indications Endometriosis; Prostate cancer
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 15 Apr 2014 New trial record